Search research articles
Contact Us
Filters
Showing results (31-40 of 65) with videos related to
Page
of 7
Sort By:
JAMA Neurology
|
May 8, 2023
Comparison of Group-Level and Individualized Brain Regions for Measuring Change in Longitudinal Tau Positron Emission Tomography in Alzheimer Disease
Antoine Leuzy, Alexa Pichet Binette, Jacob W Vogel, et al.
Journal of Alzheimer'S Disease : JAD
|
August 23, 2024
Long-Term Safety of Gantenerumab in Participants with Alzheimer's Disease: A Phase III, Double-Blind, and Open-Label Extension Study (Marguerite RoAD)
Anuja Neve, Bibha Das, Jakub Wojtowicz, et al.
Annals of Neurology
|
January 20, 2026
Toward Harmonizing Quantification of Dopamine Neuron Imaging Biomarkers in Parkinson's Disease: The Centamine Scale
Zhen Fan, Graham Searle, Gaia Rizzo, et al.
Alzheimer'S Research & Therapy
|
December 10, 2017
A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease
Susanne Ostrowitzki, Robert A Lasser, Ernest Dorflinger, et al.
JAMA Neurology
|
November 18, 2024
Amyloid-Related Imaging Abnormalities (ARIA) in Clinical Trials of Gantenerumab in Early Alzheimer Disease
Stephen Salloway, Jakub Wojtowicz, Nicola Voyle, et al.
Alzheimer'S Research & Therapy
|
September 29, 2018
Correction to: A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease
Susanne Ostrowitzki, Robert A Lasser, Ernest Dorflinger, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Drug Development
Luka Kulic, Fabien Alcaraz, Gregory Klein, et al.
JAMA Neurology
|
December 20, 2021
Biomarker-Based Prediction of Longitudinal Tau Positron Emission Tomography in Alzheimer Disease
Antoine Leuzy, Ruben Smith, Nicholas C Cullen, et al.
Journal of Alzheimer'S Disease : JAD
|
December 17, 2024
Long-term safety of gantenerumab in participants with Alzheimer's disease: A phase III, open-label extension study (SCarlet RoAD)
Mercè Boada, Anuja Neve, Bibha Das, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Drug Development
Janice Smith, Catherine J Mummery, Jeffrey L Cummings, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 65) with videos related to
Sort By:
Page
of 7
JAMA Neurology
|
May 8, 2023
Comparison of Group-Level and Individualized Brain Regions for Measuring Change in Longitudinal Tau Positron Emission Tomography in Alzheimer Disease
Antoine Leuzy, Alexa Pichet Binette, Jacob W Vogel, et al.
Journal of Alzheimer'S Disease : JAD
|
August 23, 2024
Long-Term Safety of Gantenerumab in Participants with Alzheimer's Disease: A Phase III, Double-Blind, and Open-Label Extension Study (Marguerite RoAD)
Anuja Neve, Bibha Das, Jakub Wojtowicz, et al.
Annals of Neurology
|
January 20, 2026
Toward Harmonizing Quantification of Dopamine Neuron Imaging Biomarkers in Parkinson's Disease: The Centamine Scale
Zhen Fan, Graham Searle, Gaia Rizzo, et al.
Alzheimer'S Research & Therapy
|
December 10, 2017
A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease
Susanne Ostrowitzki, Robert A Lasser, Ernest Dorflinger, et al.
JAMA Neurology
|
November 18, 2024
Amyloid-Related Imaging Abnormalities (ARIA) in Clinical Trials of Gantenerumab in Early Alzheimer Disease
Stephen Salloway, Jakub Wojtowicz, Nicola Voyle, et al.
Alzheimer'S Research & Therapy
|
September 29, 2018
Correction to: A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease
Susanne Ostrowitzki, Robert A Lasser, Ernest Dorflinger, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Drug Development
Luka Kulic, Fabien Alcaraz, Gregory Klein, et al.
JAMA Neurology
|
December 20, 2021
Biomarker-Based Prediction of Longitudinal Tau Positron Emission Tomography in Alzheimer Disease
Antoine Leuzy, Ruben Smith, Nicholas C Cullen, et al.
Journal of Alzheimer'S Disease : JAD
|
December 17, 2024
Long-term safety of gantenerumab in participants with Alzheimer's disease: A phase III, open-label extension study (SCarlet RoAD)
Mercè Boada, Anuja Neve, Bibha Das, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Drug Development
Janice Smith, Catherine J Mummery, Jeffrey L Cummings, et al.
Page
of 7